Use of alpha-methylglucoside (AMG) as an indicator for glucose absorption and excretion

Details for Australian Patent Application No. 2010295722 (hide)

Owner Janssen Pharmaceutica, N.V.

Inventors Demarest, Keith T.; Lenhard, James M.; Leo, Gregory C.; Liang, Yin; Martin, Tonya L.

Agent Shelston IP

Pub. Number AU-A-2010295722

PCT Pub. Number WO2011/034846

Priority 61/242,570 15.09.09 US

Filing date 14 September 2010

Wipo publication date 24 March 2011

International Classifications

G01N 33/50 (2006.01) Investigating or analysing materials by specific methods not covered by groups - Chemical analysis of biological material, e.g. blood, urine

A61K 49/00 (2006.01) Preparations for testing

Event Publications

12 April 2012 PCT application entered the National Phase

  PCT publication WO2011/034846 Priority application(s): WO2011/034846

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010295739-A system for transformation of the chloroplast genome of Scenedesmus sp. and Dunaliella sp.

2010295717-ABT-263 crystalline forms and solvates for use in treating Bcl-2 protein related diseases